Think about adding ivermectin to your cancer protocol

Cancer is a dreaded diagnosis, and the treatment doesn’t give much hope.  The last statistics I looked at showed major cancer hospitals having a .25% success rate.  Also, cancer is one of the fastest growing causes of mortality in the world.  New research on ivermectin is showing promise as a standalone drug and as an add-on to chemo protocols.

Ivermectin is normally used as an anti-parasitic drug.  You may have initially heard of it as an alternative measure in the recent pandemic.  The first reports of cancer use were seen in research in 1995.

  • Dr. Alfonso Duenas-Gonzales says that there are4 9 perfectly defined cancer targets.
  • A Japanese study looked at lung, bone and breast cancers, and found that adding ivermectin to the protocol showed enhanced results.
  • Dr. Peter P. Lee has done research with ivermectin and breast cancer.
  • Dr. Martin Gleave’s research shows that ivermectin inhibits HSP27, which is a stress protein that is released after chemo and radiation therapies.

Research shows that ivermectin is beneficial for these cancers:

  • Prostate
  • Kidney
  • Esophageal
  • Breast
  • Ovarian
  • Lung
  • Glioblastoma
  • Stomach
  • Colon
  • Liver
  • Lymphoma
  • Uterus
  • Pancreas and

Ivermectin inhibits cancer growth by changing its mitochondrial function, blocking its ability to grow new blood vessels, and damaging the cancer’s DNA.

Synergistic Anti-tumor Effect of Dichloroacetate and Ivermectin – PMC (

Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer | npj Breast Cancer (

Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor models – PubMed (

Ivermectin and Pembrolizumab for the Treatment of Metastatic Triple Negative Breast Cancer – NCI

Until next time,

Dr. Polly